We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+1.22%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$57.1B
AUM Growth
-$109M
(-0.19%)
Cap. Flow
-$507M
Cap. Flow
% of AUM
-0.89%
Top 10 Holdings %
Top 10 Hldgs %
13.27%
Holding
3,274
New
730
Increased
855
Reduced
816
Closed
774
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$444M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$430M |
| 3 |
Wells Fargo
WFC
|
+$281M |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$263M |
| 5 |
ConocoPhillips
COP
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$777M |
| 2 |
Meta Platforms (Facebook)
META
|
+$317M |
| 3 |
TSMC
TSM
|
+$308M |
| 4 |
JPMorgan Chase
JPM
|
+$246M |
| 5 |
ASML
ASML
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 9.54% |
| 2 | Consumer Discretionary | 9.3% |
| 3 | Financials | 8.79% |
| 4 | Technology | 8.62% |
| 5 | Healthcare | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
RUM Group Inc
RUM
$1.91B
| $99.8K | ﹤0.01% |
17,976
-32,766
| -65% | -$211K |
|
2377
Heron Therapeutics
HRTX
$61.5M
| $94K | ﹤0.01% |
+26,868
| New | +$82.5K |
|
|
QVCGA
2378
DELISTED
QVC Group Inc Series A
QVCGA
| $90.9K | ﹤0.01% |
2,886
-2,955
| -51% | -$123K |
|
2379
Cytek Biosciences
CTKB
$616M
| $90.6K | ﹤0.01% |
16,238
-29,529
| -65% | -$177K |
|
2380
Sera Prognostics
SERA
$77.9M
| $90.2K | ﹤0.01% |
15,232
-4,727
| -24% | -$42.3K |
|
2381
Stem
STEM
$52.8M
| $86.6K | ﹤0.01% |
+3,903
| New | +$114K |
|
2382
Caribou Biosciences
CRBU
$168M
| $86K | ﹤0.01% |
52,419
-110,264
| -68% | -$352K |
|
|
EMX
2383
DELISTED
EMX Royalty
EMX
| $85.7K | ﹤0.01% |
+47,620
| New | +$90.6K |
|
2384
NovaGold Resources
NG
$3.37B
| $84.4K | ﹤0.01% |
+24,392
| New | +$80.9K |
|
2385
FuelCell Energy
FCEL
$1.54B
| $82.9K | ﹤0.01% |
4,325
+3,532
| +445% | +$94.7K |
|
2386
Alignment Healthcare
ALHC
$2.74B
| $81.7K | ﹤0.01% |
+10,442
| New | +$68.2K |
|
2387
MBIA
MBI
$253M
| $81.4K | ﹤0.01% |
14,832
-16,634
| -53% | -$99.6K |
|
2388
Talkspace
TALK
$869M
| $79.8K | ﹤0.01% |
34,711
-77,757
| -69% | -$224K |
|
|
AUTL
2389
Autolus Therapeutics
AUTL
$620M
| $77.4K | ﹤0.01% |
22,242
-38,686
| -63% | -$167K |
|
2390
Personalis
PSNL
$1.5B
| $77.1K | ﹤0.01% |
+65,895
| New | +$90.4K |
|
2391
ChargePoint
CHPT
$162M
| $76.2K | ﹤0.01% |
+2,524
| New | +$82.2K |
|
2392
Gerdau
GGB
$9.2B
| $74.1K | ﹤0.01% |
+22,446
| New | +$79.3K |
|
2393
Digital Turbine
APPS
$1.58B
| $72.5K | ﹤0.01% |
43,654
-8,274
| -16% | -$16K |
|
2394
Unisys
UIS
$205M
| $72.1K | ﹤0.01% |
17,450
-44,814
| -72% | -$219K |
|
2395
CorMedix
CRMD
$573M
| $71.2K | ﹤0.01% |
+16,446
| New | +$83.5K |
|
2396
Biomea Fusion
BMEA
$93.5M
| $70.6K | ﹤0.01% |
15,699
-11,425
| -42% | -$116K |
|
2397
Fulcrum Therapeutics
FULC
$282M
| $70.5K | ﹤0.01% |
11,367
-4,342
| -28% | -$32.9K |
|
|
OPI
2398
DELISTED
Office Properties Income Trust
OPI
| $70K | ﹤0.01% |
+34,335
| New | +$74.7K |
|
2399
Outset Medical
OM
$90.6M
| $64.9K | ﹤0.01% |
+1,124
| New | +$55.1K |
|
2400
AMC Entertainment Holdings
AMC
$2.14B
| $63.4K | ﹤0.01% |
12,736
-1,469,039
| -99% | -$5.9M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q2 2024 Portfolio in Review
As of Q2 2024, Balyasny Asset Management held 3,274 positions worth $57.1B, down 0.19% from $57.2B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Balyasny Asset Management's Q2 2024 filing shows 730 new, 855 increased, 816 reduced and 774 closed positions. Its largest new stake was Intercontinental Exchange: 1,498,857 shares worth $205M. The largest sale was Pioneer Natural Resource Co., an estimated $777M.
By sector, the portfolio is most concentrated in Industrials at 9.5% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Financials.
- Balyasny Asset Management's largest Q2 2024 buy was Intercontinental Exchange: 1,498,857 shares worth $205M.
- Balyasny Asset Management added most to Apple in Q2 2024, an estimated $444M increase.
- Balyasny Asset Management's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $317M.
- Balyasny Asset Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $777M.
- Balyasny Asset Management's ten largest holdings make up 13% of its $57.1B portfolio in Q2 2024.
- Balyasny Asset Management opened 730 new positions and closed 774 in Q2 2024.
- Balyasny Asset Management's portfolio value fell 0.19% quarter-over-quarter to $57.1B.
Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.